These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19575912)

  • 1. [The expression of vascular endothelial growth factor of vitreous in patients with proliferative diabetic retinopathy].
    Yan H; Cui J; Yu JG; Han JD; Chen S; Zhang JK; Xu YH
    Zhonghua Yan Ke Za Zhi; 2009 Mar; 45(3):206-9. PubMed ID: 19575912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
    Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
    Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
    Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED).
    Querques G; Delle Noci N
    Retina; 2009 Jan; 29(1):121-3; author reply 123. PubMed ID: 18936719
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Iwasaki T; Ohno A; Goto H
    Retina; 2011 Oct; 31(9):1951-7. PubMed ID: 21610567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
    Liinamaa MJ; Savolainen MJ
    Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
    Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
    Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.